Literature DB >> 24985063

Mouse GDF9 decreases KITL gene expression in human granulosa cells.

Astrud R Tuck1, David G Mottershead, Herman A Fernandes, Robert J Norman, Wayne D Tilley, Rebecca L Robker, Theresa E Hickey.   

Abstract

Kit ligand (KITL) is an important granulosa cell-derived growth factor in ovarian folliculogenesis, but its expression and function in human granulosa cells are currently poorly understood. Based on studies performed in animal models, it was hypothesised that KITL gene expression in human granulosa cells is regulated by androgens and/or growth differentiation factor 9 (GDF9). We utilised two models of human granulosa cells, the KGN granulosa tumour cell line and cumulus granulosa cells obtained from preovulatory follicles of women undergoing assisted reproduction. Cells were treated with combinations of 5α-dihydrotestosterone (DHT), recombinant mouse GDF9, and the ALK4/5/7 inhibitor SB431542. KITL mRNA levels were measured by quantitative real-time PCR. No change in KITL mRNA expression was observed after DHT treatment under any experimental conditions, but GDF9 treatment resulted in a significant decrease in KITL mRNA levels in both KGN and cumulus cells. The effect of GDF9 was abolished by the addition of SB431542. These results indicate that KITL is not directly regulated by androgen signalling in human granulosa cells. Moreover, this study provides the first evidence that GDF9 negatively regulates KITL gene expression in human granulosa cells providing new information on the regulation of these important growth factors in the human ovary.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24985063     DOI: 10.1007/s12020-014-0335-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  50 in total

1.  Comparison of recombinant growth differentiation factor-9 and oocyte regulation of KIT ligand messenger ribonucleic acid expression in mouse ovarian follicles.

Authors:  I M Joyce; A T Clark; F L Pendola; J J Eppig
Journal:  Biol Reprod       Date:  2000-12       Impact factor: 4.285

2.  Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2.

Authors:  E J Huang; K H Nocka; J Buck; P Besmer
Journal:  Mol Biol Cell       Date:  1992-03       Impact factor: 4.138

3.  Parabens inhibit the early phase of folliculogenesis and steroidogenesis in the ovaries of neonatal rats.

Authors:  Hyo-Jin Ahn; Beum-Soo An; Eui-Man Jung; Hyun Yang; Kyung-Chul Choi; Eui-Bae Jeung
Journal:  Mol Reprod Dev       Date:  2012-07-26       Impact factor: 2.609

Review 4.  Advances in adjuvant therapy of gastrointestinal stromal tumors.

Authors:  K Adekola; M Agulnik
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

5.  Small glutamine-rich tetratricopeptide repeat-containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome.

Authors:  Miriam S Butler; Xing Yang; Carmela Ricciardelli; Xiaoyan Liang; Robert J Norman; Wayne D Tilley; Theresa E Hickey
Journal:  Fertil Steril       Date:  2013-02-20       Impact factor: 7.329

6.  Signalling pathways mediating specific synergistic interactions between GDF9 and BMP15.

Authors:  David G Mottershead; Lesley J Ritter; Robert B Gilchrist
Journal:  Mol Hum Reprod       Date:  2011-09-12       Impact factor: 4.025

7.  Activation of latent human GDF9 by a single residue change (Gly 391 Arg) in the mature domain.

Authors:  Courtney M Simpson; Peter G Stanton; Kelly L Walton; Karen L Chan; Lesley J Ritter; Robert B Gilchrist; Craig A Harrison
Journal:  Endocrinology       Date:  2012-01-10       Impact factor: 4.736

8.  Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells.

Authors:  David G Mottershead; Minna M Pulkki; Pranuthi Muggalla; Arja Pasternack; Minna Tolonen; Samu Myllymaa; Olexandr Korchynskyi; Yoshihiro Nishi; Toshihiko Yanase; Stan Lun; Jennifer L Juengel; Mika Laitinen; Olli Ritvos
Journal:  Mol Cell Endocrinol       Date:  2007-11-19       Impact factor: 4.102

9.  Androgen receptor expression in human ovarian and uterine tissue of long-term androgen-treated transsexual women.

Authors:  S Chadha; T D Pache; J M Huikeshoven; A O Brinkmann; T H van der Kwast
Journal:  Hum Pathol       Date:  1994-11       Impact factor: 3.466

10.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

Authors:  Gareth J Inman; Francisco J Nicolás; James F Callahan; John D Harling; Laramie M Gaster; Alastair D Reith; Nicholas J Laping; Caroline S Hill
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.